SARS News and Research

RSS
Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

SARS-CoV-2 interacts with unusual RNA structures in human cells

SARS-CoV-2 interacts with unusual RNA structures in human cells

One dose of mRNA vaccine reduced COVID risk for at least four months in health care workers

One dose of mRNA vaccine reduced COVID risk for at least four months in health care workers

Budesonide’s antiviral effect against SARS-CoV-2

Budesonide’s antiviral effect against SARS-CoV-2

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

Sick leave eligibility rules in the U.S. widen racial inequalities in the labor market, finds study

Sick leave eligibility rules in the U.S. widen racial inequalities in the labor market, finds study

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

SARS-CoV-2 antibodies in breast milk: Study

SARS-CoV-2 antibodies in breast milk: Study

COVID-19 lockdown linked to fall in early childhood vaccination in England, a rise in Scotland

COVID-19 lockdown linked to fall in early childhood vaccination in England, a rise in Scotland

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Rosin soap as a potential SARS-CoV-2 disinfectant

Rosin soap as a potential SARS-CoV-2 disinfectant

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

SARS-CoV-2 delta variant associated with several vaccine breakthrough cases in Houston

SARS-CoV-2 delta variant associated with several vaccine breakthrough cases in Houston

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

5.6% seroprevalence of SARS-CoV-2 antibodies in England during second wave

CoVizu: Making visual sense of variation in SARS-CoV-2 genomes

CoVizu: Making visual sense of variation in SARS-CoV-2 genomes

CD8+ T cells show gene-dependent variation in cross-reactivity to human coronaviruses

CD8+ T cells show gene-dependent variation in cross-reactivity to human coronaviruses

Activation of integrins by SARS-CoV-2 may be key to infection

Activation of integrins by SARS-CoV-2 may be key to infection